[11C]savolitinib
- Generic Name
- [11C]savolitinib
A Positron-emission Tomography Study to Determine Brain Exposure of [11C]Savolitinib in Healthy Volunteers
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 7
- Registration Number
- NCT06348355
- Locations
- 🇸🇪
Research Site, Solna, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath